威尔药业: 威尔药业2024年年度股东大会法律意见书

Core Points - The legal opinion letter confirms the legality and validity of the 2024 annual general meeting of Nanjing Weier Pharmaceutical Group Co., Ltd. [1][5] - The meeting is scheduled for May 15, 2025, and will include provisions for online voting [2][3] Group 1: Meeting Procedures - The board of directors decided to hold the annual general meeting on May 15, 2025, and the notice was published in relevant newspapers [1][2] - The notice included details such as the time, location, and voting procedures, ensuring compliance with legal requirements [2][3] Group 2: Attendance and Voting - A total of 110 participants attended the meeting, representing 98,650,090 voting shares, which is 72.8372% of the total shares [3][5] - The meeting included 10 attendees present at the venue and 100 participants voting online, with the online voting system adhering to regulatory standards [3][4] Group 3: Voting Process and Results - The voting was conducted through a named voting method, and the results were verified by the Shanghai Stock Exchange's information network company [5] - The meeting's resolutions were consistent with the announced agenda, and the voting process complied with relevant regulations [5]